ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Since BCR-ABL (P210) mediates the initiation, maintenance and progression of CML and it positively regulate c-Myc expression, we investigated whether JOA reduced the mRNA and protein expression level of BCR-ABL in both BaF3-T315I and K562 cell lines.